These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 769954)

  • 1. Trial of hydrazine sulfate (NSC-150014) in patients with cancer.
    Ochoa M; Wittes RE; Krakoff IH
    Cancer Chemother Rep; 1975; 59(6):1151-4. PubMed ID: 769954
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of clinical study antitumor action of hydrazine sulfate.
    Gershanovich ML; Danova LA; Ivin BA; Filov VA
    Nutr Cancer; 1981; 3(1):7-12. PubMed ID: 7050922
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical study of hydrazine sulfate in advanced cancer patients.
    Spremulli E; Wampler GL; Regelson W
    Cancer Chemother Pharmacol; 1979; 3(2):121-4. PubMed ID: 389477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabolic profiles in late-stage cancer patients responsive to hydrazine sulfate.
    Gold J
    Nutr Cancer; 1981; 3(1):13-9. PubMed ID: 7050921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Unproven methods of cancer management: hydrazine sulfate.
    CA Cancer J Clin; 1976; 26(2):108-10. PubMed ID: 816429
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydrazine sulfate used in cancer patients.
    Smigel K
    J Natl Cancer Inst; 1990 Feb; 82(4):254. PubMed ID: 2405169
    [No Abstract]   [Full Text] [Related]  

  • 7. [The results of a clinical study of the preparation hydrazine sulfate].
    Filov VA; Danova LA; Gershanovich ML; Ivin BA; Dement'eva NP; Breĭvis PV; Ragaĭshene VP; Kas'ianenko IV; Lisitsa AM; Mindlin SS
    Vopr Onkol; 1990; 36(6):721-6. PubMed ID: 2198698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of hexamethylmelamine (NSC-13875).
    Bergevin PR; Tormey DC; Blom J
    Cancer Chemother Rep; 1973 Feb; 57(1):51-8. PubMed ID: 4704103
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydrazine sulfate: a current perspective.
    Gold J
    Nutr Cancer; 1987; 9(2-3):59-66. PubMed ID: 3104888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of twice weekly 5-azacytidine (NSC-102816).
    Vogler WR; Arkun S; Velez-Garcia E
    Cancer Chemother Rep; 1974; 58(6):895-9. PubMed ID: 4141280
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical pharmacologic study of 1-acetyl-2-picolinoyl hydrazine (NSC-68626).
    Laszlo J; Durant J; Loeb V
    Cancer Chemother Rep; 1969 Apr; 53(2):131-4. PubMed ID: 4895097
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of hydrazine sulfate on abnormal carbohydrate metabolism in cancer patients with weight loss.
    Chlebowski RT; Heber D; Richardson B; Block JB
    Cancer Res; 1984 Feb; 44(2):857-61. PubMed ID: 6692384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of carcinoma of the lung with 1-acetyl-2-picolinoylhydrazine (NSC-68626).
    Wilson KS; Ricci JA; Grobmyer AJ
    Cancer Chemother Rep; 1970 Aug; 54(4):243-4. PubMed ID: 4946008
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental and clinical data on the antitumor action of hydrazine sulfate].
    Seĭts IF; Gershanovich ML; Filov VA; Danova LA; Kondrat'ev VB
    Vopr Onkol; 1975; 21(1):45-52. PubMed ID: 1090085
    [No Abstract]   [Full Text] [Related]  

  • 15. Unconventional therapies for cancer: 4. Hydrazine sulfate. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
    Kaegi E
    CMAJ; 1998 May; 158(10):1327-30. PubMed ID: 9614826
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of hydrazine sulfate in terminal and preterminal cancer patients: results of investigational new drug (IND) study in 84 evaluable patients.
    Gold J
    Oncology; 1975; 32(1):1-10. PubMed ID: 1208024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical data on the antitumor activity of hydrazine sulfate.
    Gershanovich ML; Danova LA; Kondratyev VB; Malyugina LL; Stukov AN; Seitz JF; Filov VA
    Cancer Treat Rep; 1976 Jul; 60(7):933-5. PubMed ID: 1009524
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of hydrazine sulfate on galactosamine-sensitized endotoxic shock in ten-day-old rats.
    Ravindranath T; Topaloglu AK; Goto M; Zeller WP
    Res Commun Mol Pathol Pharmacol; 1998 Feb; 99(2):233-9. PubMed ID: 9583097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)].
    Steinhäusl H
    Wien Med Wochenschr; 1973 Jun; 123(26):433-5. PubMed ID: 4578743
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trial of the oral form of a new podophyllotoxin derivative, VP-16-213 (NSC-141540), in patients with advanced neoplastic disease.
    Nissen NI; Hansen HH; Pedersen H; Stroyer I; Dombernowsky P; Hessellund M
    Cancer Chemother Rep; 1975; 59(5):1027-9. PubMed ID: 1106845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.